Trademark: 87331894
Word
PIVAT
Status
Registered
Status Code
700
Status Date
Tuesday, July 3, 2018
Serial Number
87331894
Registration Number
5509369
Registration Date
Tuesday, July 3, 2018
Mark Type
4000
Filing Date
Friday, February 10, 2017
Published for Opposition
Tuesday, August 15, 2017

Trademark Owner History
Pillar Biosciences, Inc. - Original Registrant

Classifications
9 computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; computer software for analyzing biological samples; computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; computer software for use with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing
44 Collection, management, and analysis of data in the field of medical diagnostics; providing biological sample testing services for others in the field of medical diagnostics; providing biological sample testing services for others for medical purposes, namely, for the diagnosis and treatment of cancer; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the field of medical diagnostics
42 Software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; software as a service (Saas), namely, hosting non-downloadable computer software for use by others for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; collection, management, and analysis of data in the fields of scientific research, clinical research and scientific diagnostics; providing biological sample testing services for others in the fields of scientific research, clinical research and scientific diagnostics; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, and scientific diagnostics research; providing bioinformatics and gene expression microarray image analysis services for others, namely, performing gene expression quantification, gene image processing, and gene information processing for others

Trademark Events
Jul 3, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 3, 2018
Registered-Principal Register
May 31, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
May 30, 2018
Allowed Principal Register - Sou Accepted
May 8, 2018
Statement Of Use Processing Complete
Apr 10, 2018
Use Amendment Filed
Apr 27, 2018
Case Assigned To Intent To Use Paralegal
Apr 10, 2018
Teas Statement Of Use Received
Oct 10, 2017
Noa E-Mailed - Sou Required From Applicant
Aug 15, 2017
Official Gazette Publication Confirmation E-Mailed
Aug 15, 2017
Published For Opposition
Jul 26, 2017
Notification Of Notice Of Publication E-Mailed
Jul 10, 2017
Approved For Pub - Principal Register
Jun 22, 2017
Teas/Email Correspondence Entered
Jun 22, 2017
Correspondence Received In Law Office
Jun 15, 2017
Assigned To Lie
May 23, 2017
Teas Response To Office Action Received
May 9, 2017
Notification Of Non-Final Action E-Mailed
May 9, 2017
Non-Final Action E-Mailed
May 9, 2017
Non-Final Action Written
May 6, 2017
Assigned To Examiner
Feb 16, 2017
New Application Office Supplied Data Entered
Feb 14, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24